Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Intellectual Disability

About 2 per cent of children are estimated to have an intellectual disability. The cause of the condition is unknown in at least 50 per cent of cases.

Clocking TikTok expertise across the Institute

Early career researchers across The Kids Research Institute Australia have come together in a serendipitous project that is laying the groundwork for a more informed discussion of the impact of social media on kids and young people.

Impact: Collaboration

On this Research Impact page, we list stories helping demonstrate how we collaborate with other leaders, innovators, communities, and international stakeholders to ensure excellent research results. The better our results, the better the chances of research making a real difference.

News & Events

Scrolling for advice? TikTok tips a parent stitch up

Research from The Kids has revealed that approximately half of supposed 'educational' content for parents on TikTok is being uploaded by a creator without any expertise.

Young Minds Matter

Young Minds Matter is the second Australian Child and Adolescent Survey of Mental Health and Wellbeing.

Research

Immunisation

Immunisation is the most effective way of protecting your child against a range of serious illnesses, including measles, hepatitis B and whooping cough. All vaccines used in Australia undergo stringent testing and ongoing monitoring.

Research Theme

Infectious Diseases

Aims to prevent, diagnose, and treat infectious diseases, with a strong focus on developing effective vaccines and improving immunity across populations. This theme addresses both emerging and persistent infections that impact children's health worldwide.

To immunity and beyond

The quest to stop infectious diseases from killing our kids

News & Events

The Kids researchers lead national trial to fight sepsis in premature infants

The Kids Research Institute Australia researchers will lead a new national clinical trial (COSI-2) to determine whether topical coconut oil can reduce late onset sepsis in extremely preterm infants.